Skip to main content
Fig. 3 | Journal of Inflammation

Fig. 3

From: Downregulation of lncRNA-PVT1 participates in the development of progressive chronic kidney disease among patients with congestive heart failure

Fig. 3

Follow-up analysis of CHF group revealed the predictive value of plasma PVT1 for CKD in CHF patients. The 100 CHF patients were divided into high and low PVT1 level groups (n = 50; cutoff value = the median level of PVT1 in plasma samples of CHF patients). CKD-free curves were plotted and compared by log-rank test

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us